MAPT and Alzheimer disease: We evaluated a priori cut points for Aβ42, P-tau, T-tau, Aβ42/Aβ40, and P-tau/Aβ42 for primary neuropathologic diagnosis in terms of sensitivity for AD and specificity for non-AD.